ESAIY (Eisai Co) Total Equity: $5,830 Mil (As of Mar. 2026)


ESAIY Eisai Co Ltd ESAIY
66 GF Score
Price $5.98
GF Value $9.14
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Eisai Co Total Equity?

Eisai Co ESAIY +0.34% 66 Total Equity is $5,830 Mil as of Mar. 2026. GuruFocus rates ESAIY with a GF Score™ of 66/100 and a GF Value™ of $9.14 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Eisai Co's total equity for the quarter that ended in Mar. 2026 was $5,830 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Eisai Co Total Equity Historical Data

* Premium members only.

The historical data trend for Eisai Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eisai Co Total Equity Chart

Eisai Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,506.58 6,154.01 6,000.42 5,809.62 5,830.02

Eisai Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,809.62 5,907.47 5,949.91 5,872.82 5,830.02
ESAIY
66GF Score
Eisai Co Ltd ESAIY
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eisai Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Eisai Co's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=9132.142-3302.124
=5,830

Eisai Co's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=9132.142-3302.124
=5,830

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $5,830 Mil mean?
Eisai Co (ESAIY) has a Total Equity of $5,830 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Eisai Co and its competitors.
Is Eisai Co's Total Equity too high?
Eisai Co's current Total Equity is $5,830 Mil. Overall, Eisai Co has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eisai Co's Total Equity compare to ZTS?
Eisai Co's Total Equity of $5,830 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Eisai Co and its competitors. Eisai Co's current Total Equity is $5,830 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eisai Co stock overvalued right now?
Based on GuruFocus' analysis, Eisai Co (ESAIY) is currently considered Significantly Undervalued. The stock's GF Value™ is $9.14, compared to a current price of $5.98 — trading 34.6% below its estimated fair value. The current Total Equity is $5,830 Mil. Eisai Co's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Eisai Co (ESAIY), the current Total Equity is $5,830 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eisai Co (ESAIY) Overvalued in 2026?

Based on GuruFocus' analysis, Eisai Co stock appears to be undervalued. The current stock price of $5.98 is trading 34.6% below its estimated GF Value™ of $9.14. GuruFocus considers Eisai Co to be Significantly Undervalued.

Key valuation signals for ESAIY:

  • Total Equity: $5,830 Mil
  • GF Value™: $9.14 vs. price of $5.98 (34.6% below fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the ESAIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eisai Co Business Description

Address 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
66GF Score

Get the complete analysis for ESAIY

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.98
Price
$9.14
GF Value